30 Nov 2018
Omalizumab and Dornase alpha formulations needed for the US market [ENA02794]
A leading global pharmaceutical company is looking for manufacturers who can supply or are developing Omalizumab and Dornase alpha formulations for the US market.
Comments :
bd@qbdbiosciences.com
Hi We have access to Omalizumab entering Phase-1 and Dornase in Phase-3 . Other recombinant and biosimlars are also available for US market for licensing. Please share details of your company on my email id.
20:23, 30 Nov 2018
hostrinlifesciences@gmail.com
Hii, we do support for the complete formulation development for the same with 3 lab,pilot & commercial batches.
For further requirements please feel free to contact me.
Best Regards,
Andrew P
CEO & MD,
Hostrin Life Sciences,
www.hostringlobal.com
andrew@hostringlobal.com
21:35, 06 Dec 2018